Table 4. Multivariate analysis of risk... | American Society of Hematology

Table 4.

Multivariate analysis of risk factors risk factors for survival (n = 87)*

	Hazard ratio (95% CI)	P
CD3 dose
More than or equal to median, n = 37	1.0	.0006
Less than median, n = 37	2.8 (1.4-5.5)
Unknown, n = 12†	5.6 (2.1-15)
Risk group
Low, n = 18	1.0	.04
High, n = 69	2.8 (1.0-8.1)
Donor sex
Female, n = 54	1.0	.01
Male, n = 33	2.1 (1.0-4.4)
Preceding transfusion
No, n = 16	1.0	.003
Yes, n = 70	3.4 (1.0-12)
Marrow blasts at HCT
Less than or equal to 5%, n = 70	1.0	.002
More than 5%, n = 16	3.3 (1.6-6.6)

	Hazard ratio (95% CI)	P
CD3 dose
More than or equal to median, n = 37	1.0	.0006
Less than median, n = 37	2.8 (1.4-5.5)
Unknown, n = 12†	5.6 (2.1-15)
Risk group
Low, n = 18	1.0	.04
High, n = 69	2.8 (1.0-8.1)
Donor sex
Female, n = 54	1.0	.01
Male, n = 33	2.1 (1.0-4.4)
Preceding transfusion
No, n = 16	1.0	.003
Yes, n = 70	3.4 (1.0-12)
Marrow blasts at HCT
Less than or equal to 5%, n = 70	1.0	.002
More than 5%, n = 16	3.3 (1.6-6.6)

Abbreviations are explained in Table 1.

Patients who died prior to day 28 were excluded.

CD3 cell enumeration did not take place.